TMRW Life Sciences pockets $105m Series C

TMRW Life Sciences Inc, a provider of an automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization, has raised $105 million in Series C financing.

TMRW Life Sciences Inc, a provider of an automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization, has raised $105 million in Series C financing. Transformation Capital led the round.

Source: Press Release